Literature DB >> 8444871

Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation.

R Malaviya1, R Malaviya1, B A Jakschik.   

Abstract

The 5-lipoxygenase catalyzes the first two steps in the metabolism of arachidonic acid to leukotrienes. It has been shown that the calcium influx into leukocytes following stimulation by A23187 activates the enzyme and causes its translocation to the membrane. Leukotrienes are formed, and then the enzyme seems to be irreversibly inactivated. In the present investigation we have compared the effect of receptor-mediated mast cell activation (IgE/antigen) and A23187 on 5-lipoxygenase activity and translocation to the membrane. In contrast to the ionophore, IgE/antigen, which initiated the formation of similar amounts of leukotrienes as A23187, caused minor inactivation of the enzyme. Immunoblot analysis demonstrated that after antigen the membrane association of the 5-lipoxygenase was reversible, while with A23187 the translocation continued during the time of observation (60 min). Addition of a calcium chelator after ionophore challenge, prevented further inactivation of the enzyme and reversed its membrane binding. The data suggest that the continuous influx of calcium with A23187 is responsible for the extensive inactivation of the 5-lipoxygenase. In contrast, during receptor-mediated stimulation the transient increase in intracellular calcium seems to conserve the enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Janus kinase-3 dependent inflammatory responses in allergic asthma.

Authors:  Rama Malaviya; Debra L Laskin; Ravi Malaviya
Journal:  Int Immunopharmacol       Date:  2010-04-27       Impact factor: 4.932

2.  Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice.

Authors:  C L Chen; R Malaviya; C Navara; H Chen; B Bechard; G Mitcheltree; X P Liu; F M Uckun
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

Review 3.  Mast cells in infection and immunity.

Authors:  S N Abraham; R Malaviya
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48.

Authors:  R Malaviya; Z Gao; K Thankavel; P A van der Merwe; S N Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Membrane fluidity is a key modulator of membrane binding, insertion, and activity of 5-lipoxygenase.

Authors:  Abhay H Pande; Shan Qin; Suren A Tatulian
Journal:  Biophys J       Date:  2005-03-18       Impact factor: 4.033

6.  Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages.

Authors:  T G Brock; R W McNish; M Peters-Golden
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

7.  Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor.

Authors:  A N Fonteh; J M Samet; F H Chilton
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

8.  Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells.

Authors:  Sailaja Paruchuri; Yongfeng Jiang; Chunli Feng; Sanjeev A Francis; Jorge Plutzky; Joshua A Boyce
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

Review 9.  Cysteinyl leukotriene receptors, old and new; implications for asthma.

Authors:  T M Laidlaw; J A Boyce
Journal:  Clin Exp Allergy       Date:  2012-09       Impact factor: 5.018

10.  Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor.

Authors:  Sailaja Paruchuri; Hiroyuki Tashimo; Chunli Feng; Akiko Maekawa; Wei Xing; Yongfeng Jiang; Yoshihide Kanaoka; Pamela Conley; Joshua A Boyce
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.